Staphylococcus aureus bacteremia in hemodialysis patients

Journal of Dialysis
D L LatosR H Alford

Abstract

Fifteen male hemodialysis patients developed 21 episodes of S. aureus bacteremia. Infections involving vascular access were responsible for 65% of initial bacteremias. The arteriovenous fistula was the most prevalent type of access used, and thus was responsible for the majority of these illnesses. Phage typing indicated that recurrent episodes were due to reinfection rather than relapse. Complications included endocarditis, osteomyelitis, septic embolism, and pericarditis. One patient died of infectious complications. It is recommended that hemodialysis patients developing bacteremia due to S. aureus receive at least 6 weeks of beta lactamase-resistant antimicrobial therapy.

References

Mar 1, 1975·Chest·M D BischelJ G Mohler
May 1, 1975·The Journal of Infectious Diseases·R AlyA D Mandel
Dec 1, 1975·International Journal of Dermatology·G Singh
May 1, 1976·Annals of Internal Medicine·P B Iannini, K Crossley
Jul 15, 1972·Lancet·R A Kaslow, S R Zellner
May 1, 1973·Annals of Internal Medicine·A LeonardL Raij
Jul 1, 1973·Kidney International·L RaijA F Michael
May 1, 1973·Annals of Internal Medicine·N P Dreyer, B N Fields
Dec 1, 1973·Kidney International·A LeonardF L Shapiro
Nov 1, 1973·Progress in Cardiovascular Diseases·L Weinstein, R H Rubin
Sep 1, 1973·Annals of Internal Medicine·N LameireS Ringoir
Jan 1, 1968·Medicine·J Z MontgomerieL B Guze
Aug 14, 1971·British Medical Journal·A J RalstonP Davis
Jul 8, 1972·British Medical Journal·L F SaldanhaD G Mulder
Jul 1, 1967·Annals of Internal Medicine·D B LouriaJ Rose
Jul 1, 1967·Annals of Internal Medicine·C E Cherubin
Jul 18, 1970·British Medical Journal·D M JonesA J Ralston
Nov 1, 1968·Annals of Internal Medicine·L E CLUFFJ L Breckenridge
Nov 1, 1965·The American Journal of Medicine·L E CLUFF, R J Reynolds
Nov 17, 1966·The New England Journal of Medicine·M J BresciaB J Hurwich
May 12, 1966·The New England Journal of Medicine·D D Lindholm, J S Murray
Feb 1, 1961·The Journal of Experimental Medicine·K GOSHIC R CONTI
Nov 22, 1962·The New England Journal of Medicine·L D SABATHM FINLAND

Citations

Apr 16, 1999·The Journal of Hospital Infection·S J PeacockP Maxwell
Dec 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L D QuarlesS G Rostand
Mar 11, 2009·The American Journal of Medicine·Martin E StryjewskiVance G Fowler

Related Concepts

Antibiotics
Arteriovenous Anastomosis Procedure
Hemodialysis
Relapse
Skin
Staphylococcal Infections
Pyemia

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Archives of Internal Medicine
R J SherertzW D Mattern
Nephrology Nursing Journal : Journal of the American Nephrology Nurses' Association
Lesley C Dinwiddie, Cynthia Bhola
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Ayman A Geneidy, Wolfgang J Weise
© 2021 Meta ULC. All rights reserved